These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 19939719

  • 41. [Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju].
    Seo JH.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):304-14. PubMed ID: 14695697
    [Abstract] [Full Text] [Related]

  • 42. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL.
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [Abstract] [Full Text] [Related]

  • 43. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
    Gong J, Li RC, Li YP, Yang JY, Chen XR, Nong Y, Huang ZN, Li Q, Liu CB, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
    [Abstract] [Full Text] [Related]

  • 44. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian].
    Li L, Zhou Y, Zhao L, Xia S, Wang Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252
    [Abstract] [Full Text] [Related]

  • 45. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [Abstract] [Full Text] [Related]

  • 46. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN.
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine].
    Shen LP, Yang JY, Mo ZJ, Li RC, Li YP, Wei ZL, Dong YH, Zhou KJ, Wei SC, Fang KX, Yu T, Zhang WY, Zhang Y, Bi SL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):659-62. PubMed ID: 18069553
    [Abstract] [Full Text] [Related]

  • 49. Hepatitis B surface antigen confirmatory testing for diagnosis of hepatitis B virus infection in Taiwan.
    Chu FY, Su FH, Cheng SH, Lin YS, Li CY, Chien CC, Lin YC, Chiang SY.
    J Med Virol; 2011 Sep; 83(9):1514-21. PubMed ID: 21739440
    [Abstract] [Full Text] [Related]

  • 50. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.
    Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS.
    J Infect Dis; 2003 Jan 01; 187(1):134-8. PubMed ID: 12508157
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. 24 year outcomes of hepatitis B vaccination in Hangzhou, China.
    Du J, Xu Y, Wang J, Liu S, Liu Y, Zhang X, Xu E.
    Hum Vaccin Immunother; 2015 Jan 01; 11(8):2051-60. PubMed ID: 25714188
    [Abstract] [Full Text] [Related]

  • 53. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM.
    Saudi Med J; 2003 Sep 01; 24(9):991-5. PubMed ID: 12973485
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005.
    Cowie B, Karapanagiotidis T, Enriquez A, Kelly H.
    Aust N Z J Public Health; 2010 Feb 01; 34(1):72-8. PubMed ID: 20920109
    [Abstract] [Full Text] [Related]

  • 56. [Hepatitis B revaccination not indicated, even for those at increased risk].
    Isken LD, Zaaijer HL, van Steenbergen JE.
    Ned Tijdschr Geneeskd; 2009 Feb 01; 153():A415. PubMed ID: 19900310
    [Abstract] [Full Text] [Related]

  • 57. [A study on serologic markers for screening before hepatitis B vaccination].
    Hui Z, Zhao Z, Zhang L.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec 01; 15(6):351-3. PubMed ID: 7874705
    [Abstract] [Full Text] [Related]

  • 58. Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.
    Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, Hung CH, Lee CM, Changchien CS.
    Vaccine; 2006 Feb 06; 24(6):759-65. PubMed ID: 16159687
    [Abstract] [Full Text] [Related]

  • 59. [A sero-epidemiologiecal study on hepatitis B among general population in Beijing].
    Wu J, Zhang W, Han LL, Lin CY, Lin H, Xing YL, Gao P, Gong XH, Liu LR, Huang F, Liu JY, Liu LY, Wang HY, Yu HZ, Liu XJ, Tang YQ, Pu YL, Zhao W, Wang C, Zhang Z, Ma LX.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun 06; 28(6):555-7. PubMed ID: 17939383
    [Abstract] [Full Text] [Related]

  • 60. [Investigation on HBV-M among hospital workers and observation on the efficacy of vaccination against type B hepatitis].
    Wu Z, Gan C, Wang A.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun 06; 15(3):165-6. PubMed ID: 7834694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.